Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 5 of 5 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Lansoprazole | 1件: Lansoprazole Lansoprazole (Lansoprazole DR) | 1件: Lansoprazole
Lansoprazole
(Lansoprazole, LANSOPRAZOLE DR) 💬1. Lansoprazole
| 2件: ATP4A ATP4A,ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphoryl ... | 7件: 63 63, 71, 85, 98, 166, 222, 299 💬1. Lansoprazole
| ||||||||||||||||||||||||||||
| 2 | Lansoprazole 30mg | 1件: Lansoprazole Lansoprazole (Lansoprazole DR) | 1件: Lansoprazole
Lansoprazole
(Lansoprazole, LANSOPRAZOLE DR) 💬2. Lansoprazole 30mg
| 2件: ATP4A ATP4A,ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphoryl ... | 1件: 166 166 💬2. Lansoprazole 30mg
| ||||||||||||||||||||||||||||
| 3 | Lansoprazole, amoxicillin, clarithromycin | 3件: Amoxicillin Amoxicillin (Aa-lansoprazole-amoxicillin-clarithromycin),Clarithromycin (Aa-lansoprazole-amoxicillin-clarithromycin), Lansoprazole (Lansoprazole DR) 3件: Amoxicillin(Aa-lansoprazole-amoxicillin-clarithromycin), Clarithromycin(Aa-lansoprazole-amoxicill ... | 4件: Amoxicillin
Amoxicillin
,Clarithromycin , Lansoprazole (Lansoprazole, LANSOPRAZOLE DR), Amoxicillin 💬 4件: Amoxicillin , Clarithromycin , Lansoprazole (Lansoprazole, LANSOPRAZOLEDR), Amoxicillin ... 3. Lansoprazole, amoxicillin, clarithromycin
| 2件: ATP4A ATP4A,ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphoryl ... | 1件: 222 222 💬3. Lansoprazole, amoxicillin, clarithromycin
| ||||||||||||||||||||||||||||
| 4 | Lansoprazole, clarithromycin, amoxycillin | 3件: Amoxicillin Amoxicillin (Aa-lansoprazole-amoxicillin-clarithromycin),Clarithromycin (Aa-lansoprazole-amoxicillin-clarithromycin), Lansoprazole (Lansoprazole DR) 3件: Amoxicillin(Aa-lansoprazole-amoxicillin-clarithromycin), Clarithromycin(Aa-lansoprazole-amoxicill ... | 4件: Amoxicillin
Amoxicillin
,Clarithromycin , Lansoprazole (Lansoprazole, LANSOPRAZOLE DR), Amoxicillin 💬 4件: Amoxicillin , Clarithromycin , Lansoprazole (Lansoprazole, LANSOPRAZOLEDR), Amoxicillin ... 4. Lansoprazole, clarithromycin, amoxycillin
| 2件: ATP4A ATP4A,ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphoryl ... | 1件: 63 63 💬4. Lansoprazole, clarithromycin, amoxycillin
| ||||||||||||||||||||||||||||
| 5 | Treat with lansoprazole 30 mg BID for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms Treat with lansoprazole30 mg BID for 2 weeks, endoscopic examination with esophageal biopsy for pati ... | 1件: Lansoprazole Lansoprazole (Lansoprazole DR) | 1件: Lansoprazole
Lansoprazole
(Lansoprazole, LANSOPRAZOLE DR) 💬5. Treat with lansoprazole 30 mg BID for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms
| 2件: ATP4A ATP4A,ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphoryl ... | 1件: 98 98 💬5. Treat with lansoprazole 30 mg BID for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms
|